Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date
Vincent Chau, Marijo Bilusic Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USACorrespondence: Marijo Bilusic Tel +1-301-765-4457Fax +1-240-541-4548Email marijo.bilusic@nih.govAbstract: Over the last 18 mon...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2020-08-01
|
| Cyfres: | Cancer Management and Research |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.dovepress.com/pembrolizumab-in-combination-with-axitinib-as-first-line-treatment-for-peer-reviewed-article-CMAR |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|